DLBCL developed into fatal liver failure during rituximab-containing chemotherapy.

DLBCL developed into fatal liver failure during rituximab-containing chemotherapy. J Clin Exp Hematop. 2019;59(2):93-95 Authors: Shimazu Y, Nohgawa M PMID: 31257349 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31257349?dopt=Abstract

Source: Journal of Clinical and Experimental Hematopathology : JCEH - July 2, 2019 Category: Hematology Tags: J Clin Exp Hematop Source Type: research

More News: Chemotherapy | Hematology | Liver | Rituxan | Urology & Nephrology